Regulation - Research, Global

Filter

Current filters:

ResearchGlobal

Popular Filters

Pace of drug approvals to moderate for global pharma companies, says Fitch Ratings

21-05-2013

Global pharmaceutical novel drug approvals will moderate in 2013 due to the exceptional research success…

BiotechnologyGlobalNorth AmericaPharmaceuticalRegulationResearch

Europe falling behind USA and China as attractive for life sciences sector

22-04-2013

Intellectual property specialists Marks & Clerk's latest Life Sciences Report unveils the changing landscape…

BiotechnologyFinancialGlobalPatentsPharmaceuticalRegulationResearch

Support for introduction of a global regulatory process for biosimilars

16-04-2013

The majority of surveyed US and European physicians and payers are in favor of the introduction of a…

BiotechnologyGenericsGlobalRegulationResearch

EMA reports on patient recruitment and geographical location of clinical trials

10-04-2013

Almost 62% of the patients in pivotal trials submitted in marketing-authorisation applications (MAAs)…

BiotechnologyEuropeGlobalPharmaceuticalRegulationResearch

OECD urges harmonization of clinical trial regulations to boost medical R&D

25-02-2013

Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and…

BiotechnologyGlobalPharmaceuticalRegulationResearch

More guidelines needed to grow regenerative medicine market, report finds

11-06-2012

Standardized research guidelines are needed to control and encourage the development of gene therapy…

BiotechnologyFinancialGlobalPoliticsRegulationResearch

Key considerations for successful biosimilar development viewed by Quintiles

03-10-2011

Regulatory and commercial considerations are the primary drivers for successful biosimilar clinical development,…

BiotechnologyGenericsGlobalQuintilesRegulationResearch

Company Spotlight

ImmunoGen

ImmunoGen

Back to top